PTGX
Protagonist Therapeutics, Inc.
Stock
$140.06+0.87 (+0.63%)Close Oct 2, 2026
- Operating cash flow, 2025
- $58M
- YoY, 2025
- −68.7%
Operating cash flow
Operating cash flow by fiscal year
| Period | Operating cash flow | YoY |
|---|---|---|
| 2025 | $58M | −68.7% |
| 2024 | $184M | — |
| 2023 | −$70M | — |
| 2022 | −$108M | — |
| 2021 | −$108M | — |
| 2020 | −$72M | — |
| 2019 | −$42M | — |
| 2018 | −$50M | — |
| 2017 | $3.9M | — |
| 2016 | −$30M | — |
| 2015 | −$14M | — |
| 2014 | −$7.7M | — |